Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 2, 2008
Company announced positive one-year results from the world's largest post-approval, prospective registry for a single drug-eluting stent (DES)
-
Sep 1, 2008
Overall results demonstrated no statistically significant differences between PCI and CABG in rates of death or myocardial infarction (MI)
-
Aug 29, 2008
Boston Scientific obligation reduced from $250 to $19 million; Company to appeal remaining award
-
Aug 26, 2008
Company to present data from landmark SYNTAX clinical trial
-
Jul 21, 2008
"We were pleased with the quarter, especially with our expense management and working capital initiatives,” said CEO Jim Tobin.